PGEN:NASDAQ
Precigen Inc
7,36 US$
arrow_downward
-1,67%(-0,12) 1D
7,35 US$
arrow_downward
-0,07% (-0,0050)bedtimeAfter hours
Closed: 14 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
7,48 US$
High
7,70 US$
Low
7,33 US$
Mkt. cap
2,63 მლრდ.
Avg. vol.
4,68 მლნ.
Volume
4,19 მლნ.
52-wk high
8,98 US$
52-wk low
3,04 US$
EPS
-1,10 US$
Beta
0,92
Shares outstanding
358,04 მლნ.
No. of employees
160
Open
7,48 US$
High
7,70 US$
Low
7,33 US$
Mkt. cap
2,63 მლრდ.
Avg. vol.
4,68 მლნ.
Volume
4,19 მლნ.
52-wk high
8,98 US$
52-wk low
3,04 US$
EPS
-1,10 US$
Beta
0,92
Shares outstanding
358,04 მლნ.
No. of employees
160
News stories
From web sources and news partners
Yahoo Finance
·
2 დღის წინ
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc